Skip to Content

Patient Opportunity C LMOPX

Medalist Rating as of | See Miller Value Investment Hub
  • NAV / 1-Day Return 23.41  /  0.04 %
  • Total Assets 1.2 Bil
  • Adj. Expense Ratio
    2.260%
  • Expense Ratio 2.260%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Mid-Cap Blend
  • Investment Style Mid Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield
  • Turnover 40%

Morningstar’s Analysis LMOPX

Will LMOPX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still volatile after a leadership transition.

Associate Director Andrew Daniels

Andrew Daniels

Associate Director

Summary

Patient Opportunity has a new name, lead manager, and parent company, but its long-standing traits remain the same.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LMOPX

  • Current Portfolio Date
  • Equity Holdings 38
  • Bond Holdings 1
  • Other Holdings 3
  • % Assets in Top 10 Holdings 44.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
5.61
79,450,000
Consumer Cyclical
5.46
77,302,500
Consumer Cyclical
4.81
68,153,000
Financial Services
4.62
65,430,000
Communication Services
4.46
63,135,000
Energy
4.36
61,684,000
Consumer Cyclical
4.07
57,582,000
Financial Services
3.79
53,650,000
Industrials
3.48
49,300,000
Financial Services
3.47
49,130,250
Communication Services